We next used immunohistochemical staining of GBM IDH-WT surgical specimens (n = 28) to assess HLA-A expression and various TIL and immune markers, comparing the HLA-A high and low groups (Fig. 3a). The gene discussed is HLA-A; the disease is glioblastoma.